Michael R. Kuettel

Radiation Oncology

665 Elm St
Buffalo, NY 14203

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

NCCN Guidelines® Insights: Prostate Cancer, Version 5.2026.

NCCN Guidelines® Insights: Prostate Cancer, Version 5.2026.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: May 14, 2026

Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology.

Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: November 10, 2025

PSMA/PET-guided stereotactic radiosurgery treatment for intracranial metastases from prostate cancer.

PSMA/PET-guided stereotactic radiosurgery treatment for intracranial metastases from prostate cancer.

Journal: Discover oncology

Published: August 01, 2025

Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy.

Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy.

Journal: The Prostate

Published: February 17, 2025

NCCN Guidelines® Insights: Prostate Cancer, Version 3.2024.

NCCN Guidelines® Insights: Prostate Cancer, Version 3.2024.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 16, 2024

Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology.

Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: October 19, 2023

The impact of NCCN-compliant multidisciplinary conference on the uptake of active surveillance among eligible patients with localized prostate cancer.

The impact of NCCN-compliant multidisciplinary conference on the uptake of active surveillance among eligible patients with localized prostate cancer.

Journal: Urologic oncology

Published: July 13, 2023

Phase II Trial of Concurrent Nivolumab and Radiation Therapy for Muscle-Invasive Bladder Cancer of Older or Chemotherapy-Ineligible Patients.

Phase II Trial of Concurrent Nivolumab and Radiation Therapy for Muscle-Invasive Bladder Cancer of Older or Chemotherapy-Ineligible Patients.

Journal: International journal of radiation oncology, biology, physics

Published: January 30, 2023

NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.

NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: December 12, 2022

Impact of an NCCN-Compliant Multidisciplinary Conference on Treatment Decisions for Localized Prostate Cancer.

Impact of an NCCN-Compliant Multidisciplinary Conference on Treatment Decisions for Localized Prostate Cancer.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: June 06, 2022

NCCN Guidelines Insights: Prostate Cancer, Version 1.2021.

NCCN Guidelines Insights: Prostate Cancer, Version 1.2021.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: February 05, 2021

Oncologic outcome of radical prostatectomy versus radiotherapy as primary treatment for high and very high risk localized prostate cancer.

Oncologic outcome of radical prostatectomy versus radiotherapy as primary treatment for high and very high risk localized prostate cancer.

Journal: The Prostate

Published: September 21, 2020

Showing 1-12 of 21

Last Updated: 09/26/2026